imugene doses first patient in vaxinia phase 1 trial
Published 2 years ago • 5.1K plays • Length 6:40Download video MP4
Download video MP3
Similar videos
-
4:00
first patient dosed in imugene's pd1-vaxx combination trial
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
4:14
imugene (asx:imu) doses first patient in iv arm of phase 1 oncarlytics trial targeting solid cancers
-
5:15
imugene | first patients dosed in vaxinia mast combination study
-
5:00
imugene doses first patient in intravenous monotherapy arm of phase 1 clinical trial
-
10:00
imugene begins vaxinia trial for bile tract cancer
-
19:03
imugene steps up dosage at groundbreaking vaxinia cancer trial
-
14:33
moa of imfinzi in 1l mnsclc
-
5:04
imugene (asx:imu) | jmm & éthica capital innovation interview \ may 2024
-
5:20
imugene welcomes dosing of first patient in nextherizon phase 2 clinical trial
-
2:30
imugene thrilled as first patient dosed in phase 1 oasis trial
-
6:29
imugene finishes phase 1a monotherapy dose escalation of pd1 vaxx
-
4:43
imugene @ aacr 2020: vaxinia (cf33-hnis) phase 1 briefing
-
4:45
first cohort 3 patient dosed in checkvacc trial
-
0:34
imugene licenses potential for first “allo” car t to be approved in blood cancer
-
5:45
dosing in cohort 3 of imugene's vaxinia monotherapy dose escalation trial
-
4:54
imugene reports promising results in phase 1b trial for azer-cel in dlbcl
-
9:40
the first human trial of virus that kills cancer | imugene vaxinia explained
-
27:13
imugene investor webinar: mast study update
-
6:12
imugene @ aacr 2020: pd1-vaxx (imu-201) phase 1 briefing